Ergomar (Rosedale Therapeutics)
Welcome to the PulseAid listing for the Ergomar drug offered from Rosedale Therapeutics. This Ergotamine Derivative [EPC],Ergotamines [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Rosedale Therapeutics |
NON-PROPRIETARY NAME: | Ergotamine Tartrate |
SUBSTANCE NAME: | ERGOTAMINE TARTRATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Ergotamine Derivative [EPC],Ergotamines [Chemical/Ingredient] |
ROUTE: | SUBLINGUAL |
DOSAGE FORM: | TABLET, ORALLY DISINTEGRATING |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2012-08-31 |
END MARKETING DATE: | 0000-00-00 |
Ergomar HUMAN PRESCRIPTION DRUG Details:
Item Description | Ergomar from Rosedale Therapeutics |
LABELER NAME: | Rosedale Therapeutics |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 2(mg/1) |
START MARKETING DATE: | 2012-08-31 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 10802-1202_6ac058ea-d4f4-4fcd-83e1-5f2adb8652e6 |
PRODUCT NDC: | 10802-1202 |
APPLICATION NUMBER: | ANDA087693 |
Other ERGOTAMINE TARTRATE Pharmaceutical Manufacturers / Labelers: